Skip to main content
Erschienen in: Abdominal Radiology 6/2015

01.08.2015 | Review Article

Hybrid PET/MR imaging: physics and technical considerations

verfasst von: Shetal N. Shah, Steve S. Huang

Erschienen in: Abdominal Radiology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

In just over a decade, hybrid imaging with FDG PET/CT has become a standard bearer in the management of cancer patients. An exquisitely sensitive whole-body imaging modality, it combines the ability to detect subtle biologic changes with FDG PET and the anatomic information offered by CT scans. With advances in MR technology and advent of novel targeted PET radiotracers, hybrid PET/MRI is an evolutionary technique that is poised to revolutionize hybrid imaging. It offers unparalleled spatial resolution and functional multi-parametric data combined with biologic information in the non-invasive detection and characterization of diseases, without the deleterious effects of ionizing radiation. This article reviews the basic principles of FDG PET and MR imaging, discusses the salient technical developments of hybrid PET/MR systems, and provides an introduction to FDG PET/MR image acquisition.
Literatur
1.
Zurück zum Zitat Fowler JS, Ido T (2002) Initial and subsequent approach for the synthesis of 18FDG. Semin Nucl Med 32:6–12PubMedCrossRef Fowler JS, Ido T (2002) Initial and subsequent approach for the synthesis of 18FDG. Semin Nucl Med 32:6–12PubMedCrossRef
2.
Zurück zum Zitat Reivich M, Kuhl D, Wolf A, et al. (1977) Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol Scand 64:190–191 Reivich M, Kuhl D, Wolf A, et al. (1977) Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol Scand 64:190–191
3.
Zurück zum Zitat Som P, Atkins HL, Bandoypadhyay D, et al. (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670–675PubMed Som P, Atkins HL, Bandoypadhyay D, et al. (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670–675PubMed
4.
Zurück zum Zitat Wahl RL, Quint LE, Cieslak RD, et al. (1993) “Anatometabolic” tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 34:1190–1197PubMed Wahl RL, Quint LE, Cieslak RD, et al. (1993) “Anatometabolic” tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 34:1190–1197PubMed
5.
Zurück zum Zitat Levin DN, Pelizzari CA, Chen GT, Chen CT, Cooper MD (1988) Retrospective geometric correlation of MR, CT, and PET images. Radiology 169:817–823PubMedCrossRef Levin DN, Pelizzari CA, Chen GT, Chen CT, Cooper MD (1988) Retrospective geometric correlation of MR, CT, and PET images. Radiology 169:817–823PubMedCrossRef
6.
Zurück zum Zitat Townsend DW (2008) Combined positron emission tomography-computed tomography: the historical perspective. Semin Ultrasound, CT, MR 29:232–235CrossRef Townsend DW (2008) Combined positron emission tomography-computed tomography: the historical perspective. Semin Ultrasound, CT, MR 29:232–235CrossRef
7.
Zurück zum Zitat Veit-Haibach P, Kuhn FP, Wiesinger F, Delso G, von Schulthess G (2013) PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine. Magn Reson Mater Phys Biol Med 26:25–35CrossRef Veit-Haibach P, Kuhn FP, Wiesinger F, Delso G, von Schulthess G (2013) PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine. Magn Reson Mater Phys Biol Med 26:25–35CrossRef
8.
Zurück zum Zitat Zaidi H, Ojha N, Morich M, et al. (2011) Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 56:3091–3106PubMedCentralPubMedCrossRef Zaidi H, Ojha N, Morich M, et al. (2011) Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 56:3091–3106PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Shao Y, Cherry SR, Farahani K, et al. (1997) Simultaneous PET and MR imaging. Phys Med Biol 42:1965–1970PubMedCrossRef Shao Y, Cherry SR, Farahani K, et al. (1997) Simultaneous PET and MR imaging. Phys Med Biol 42:1965–1970PubMedCrossRef
10.
Zurück zum Zitat Bindseil GA, Gilbert KM, Scholl TJ, Handler WB, Chronik BA (2011) First image from a combined positron emission tomography and field-cycled MRI system. Magn Reson Med 66:301–305PubMedCrossRef Bindseil GA, Gilbert KM, Scholl TJ, Handler WB, Chronik BA (2011) First image from a combined positron emission tomography and field-cycled MRI system. Magn Reson Med 66:301–305PubMedCrossRef
11.
Zurück zum Zitat Delso G, Furst S, Jakoby B, et al. (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922PubMedCrossRef Delso G, Furst S, Jakoby B, et al. (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922PubMedCrossRef
12.
Zurück zum Zitat Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H (2013) MRI for attenuation correction in PET: methods and challenges. Magn Reson Mater Phys Biol Med 26:99–113CrossRef Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H (2013) MRI for attenuation correction in PET: methods and challenges. Magn Reson Mater Phys Biol Med 26:99–113CrossRef
13.
Zurück zum Zitat Wurslin C, Schmidt H, Martirosian P, et al. (2013) Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med 54:464–471PubMedCrossRef Wurslin C, Schmidt H, Martirosian P, et al. (2013) Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med 54:464–471PubMedCrossRef
14.
Zurück zum Zitat Brendle CB, Schmidt H, Fleischer S, et al. (2013) Simultaneously acquired MR/PET images compared with sequential MR/PET and PET/CT: alignment quality. Radiology 268:190–199PubMedCrossRef Brendle CB, Schmidt H, Fleischer S, et al. (2013) Simultaneously acquired MR/PET images compared with sequential MR/PET and PET/CT: alignment quality. Radiology 268:190–199PubMedCrossRef
15.
Zurück zum Zitat Schoder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274–292PubMedCrossRef Schoder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274–292PubMedCrossRef
16.
Zurück zum Zitat Adams S, Baum R, Rink T, et al. (1998) Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79–83PubMedCrossRef Adams S, Baum R, Rink T, et al. (1998) Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79–83PubMedCrossRef
17.
Zurück zum Zitat Montravers F, Kerrou K, Nataf V, et al. (2009) Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. J Clin Endocrinol Metab 94:1295–1301PubMedCrossRef Montravers F, Kerrou K, Nataf V, et al. (2009) Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. J Clin Endocrinol Metab 94:1295–1301PubMedCrossRef
18.
Zurück zum Zitat Haug AR, Cindea-Drimus R, Auernhammer CJ, et al. (2014) Neuroendocrine tumor recurrence: diagnosis with 68 Ga-DOTATATE PET/CT. Radiology 270:517–525PubMedCrossRef Haug AR, Cindea-Drimus R, Auernhammer CJ, et al. (2014) Neuroendocrine tumor recurrence: diagnosis with 68 Ga-DOTATATE PET/CT. Radiology 270:517–525PubMedCrossRef
19.
Zurück zum Zitat Afshar-Oromieh A, Malcher A, Eder M, et al. (2012) PET imaging with a [68 Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40:486–495PubMedCrossRef Afshar-Oromieh A, Malcher A, Eder M, et al. (2012) PET imaging with a [68 Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40:486–495PubMedCrossRef
20.
Zurück zum Zitat Levin C, Glover G, Deller T, et al. (2013) Prototype time-of-flight PET ring integrated with a 3T MRI system for simultaneous whole-body PET/MR imaging. J Nucl Med Meeting Abstr 54:148 Levin C, Glover G, Deller T, et al. (2013) Prototype time-of-flight PET ring integrated with a 3T MRI system for simultaneous whole-body PET/MR imaging. J Nucl Med Meeting Abstr 54:148
Metadaten
Titel
Hybrid PET/MR imaging: physics and technical considerations
verfasst von
Shetal N. Shah
Steve S. Huang
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0443-7

Weitere Artikel der Ausgabe 6/2015

Abdominal Radiology 6/2015 Zur Ausgabe

Classics in Abdominal Imaging

The yin–yang sign

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.